Riskpilot← Back to searchSign inGet full accessDr Dehdari AB
ABActiveOrg 5568548225Björngårdsgatan 7General medical practice activities · NACE 8621Est. 20111-4 employees
Revenue 2025
SEK 799K
-46% vs 2024
EBITDA margin
-15.9%
-147% vs 2024
Equity ratio
80.2%
Financial strength
Net profit 2025
SEK -114K
-152% vs 2024
| Revenue | SEK 799K | -46% |
| EBITDA | SEK -127K | -147% |
| Net profit | SEK -114K | -152% |
| Total assets | SEK 835K | -47% |
| Equity | SEK 670K | -15% |
| Employees | — | — |
Legal name
Dr Dehdari AB
Org number
5568548225
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 juni 2011
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget kommer huvudsakligen bedriva konsultverksamhet som läkare. Detta innebär framförallt arbete på vårdcentraler och sjukhus runtom i landet samt utomlands. Företaget kommer även bedriva verksamhet som skribent inom områden som medicin, etik, filosofi och litteratur.
Address
Björngårdsgatan 7
Email
drstenstromab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 50 | 1 181 | 1 139 | 1 467 | 799 |
| Staff expenses | — | — | — | −1 120 | −648 |
| EBITDA | −104 | 536 | 453 | 270 | −127 |
| Depreciation & amort. | −4 | −4 | −1 | — | — |
| EBIT | −108 | 532 | 452 | 270 | −127 |
| Net financials | — | −1 | 2 | 17 | 13 |
| Profit before tax | −108 | 531 | 454 | 287 | −114 |
| Tax | −0 | −89 | −85 | −68 | — |
| Net profit | −108 | 442 | 369 | 220 | −114 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 61 | 844 | 1 339 | 1 581 | 835 |
| Equity | 50 | 495 | 564 | 784 | 670 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 10 | 348 | 775 | 797 | 165 |
| Total debt | 10 | 348 | 775 | 797 | 165 |
EBITDA margin
-15.9%
This company
15.8%
Market median
-201% vs market
20212025
Equity ratio
80.2%
This company
38.2%
Market median
+110% vs market
20212025
Return on equity
-17.0%
This company
18.4%
Market median
-192% vs market
20212025
Net profit margin
-14.2%
This company
8.1%
Market median
-275% vs market
20212025
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20212025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BD Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Dehdari AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Behroz Dehdari | Chief Executive Officer | 0 companies |
| Farzaneh Dehdari | Deputy Board Member | 0 companies |